Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China · Delayed Price · Currency is CNY 61.26
+0.36 (0.59%)
Apr 16, 2026, 3:00 PM CST
Hangzhou Alltest Biotech Market Cap
Hangzhou Alltest Biotech has a market cap or net worth of 4.8 billion as of April 16, 2026. Its market cap has decreased by -18.24% in one year.
Market Cap
4.80B
Enterprise Value
2.35B
Revenue
911.30M
Ranking
n/a
PE Ratio
22.28
Stock Price
61.26
Market Cap Chart
Since March 25, 2021, Hangzhou Alltest Biotech's market cap has decreased from 9.38B to 4.80B, a decrease of -48.84%. That is a compound annual growth rate of -12.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 4.80B | -4.12% |
| Dec 31, 2025 | 5.00B | 1.91% |
| Dec 31, 2024 | 4.91B | -8.43% |
| Dec 29, 2023 | 5.36B | -2.86% |
| Dec 30, 2022 | 5.52B | -16.76% |
| Dec 31, 2021 | 6.63B | -29.28% |
| Mar 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BMC Medical | 6.17B |
| Zhonghong Pulin Medical Products | 5.98B |
| QITIAN Technology Group | 5.36B |
| Chimin Health Management | 5.25B |
| SWS Hemodialysis Care | 5.10B |
| Jiangxi Sanxin Medtec | 4.99B |
| Well Lead Medical | 4.06B |
| Beijing Centergate Technologies (holding) | 3.99B |